Roche Lp(a) Test Gets FDA Clearance for Cardiovascular Risk Assessment
Roche’s Tina-quant Lp(a) Gen.2 Molarity assay received FDA 510(k) clearance, supporting more precise cardiovascular risk assessment.
Read MorePosted by Andy Lundin | Jan 29, 2025 | Cardiovascular, Immunoassay |
Roche’s Tina-quant Lp(a) Gen.2 Molarity assay received FDA 510(k) clearance, supporting more precise cardiovascular risk assessment.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Point-of-Care, Sexually Transmitted Diseases |
The FDA granted 510(k) clearance for Roche STI multiplex panels, enabling rapid diagnosis of chlamydia, gonorrhea, and Mycoplasma genitalium.
Read MorePosted by Andy Lundin | Jan 16, 2025 | Molecular Diagnostics |
Scientists identified a blood marker that can diagnose asthma and assess its severity, potentially transforming asthma diagnosis.
Read MorePosted by Andy Lundin | Jan 15, 2025 | Covid 19, Point-of-Care |
The TwinDemic Detection system is a rapid and sensitive diagnostic tool that detects SARS-CoV-2 and influenza A virus simultaneously.
Read MorePosted by Andy Lundin | Jan 6, 2025 | Covid 19 |
Coordinated efforts in distributing COVID tests saved 1.4 million lives and prevented 7 million hospitalizations in the U.S.
Read More